IL-17A increases the expression of proinflammatory chemokines in human pancreatic islets

Diabetologia

Volumn 57, Issue 3, 2014, Pages 502-511

  Grieco, Fabio A ^a,b,c   Moore, Fabrice ^a   Vigneron, François ^a   Santin, Izortze ^a   Villate, Olatz ^a   Marselli, Lorella ^d   Rondas, Dieter ^e   Korf, Hannelie ^e   Overbergh, Lutgart ^e   Dotta, Francesco ^b,c   Marchetti, Piero ^d   Mathieu, Chantal ^e   Eizirik, Décio L ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF SIENA   (Italy)

^c Toscana Life Science Park   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e Division of Experimental Medicine and Endocrinology   (Belgium)

Author keywords

Apoptosis; Chemokines; Cytokines; IL 17; Pancreatic beta cells; Type 1 diabetes

Indexed keywords

IL17A PROTEIN, HUMAN; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; C57BL MOUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PANCREAS ISLET; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-17; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84894534337     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-3135-2     Document Type: Article

References (50)

1. Randow F, MacMicking JD, James LC (2013) Cellular self-defense: how cell-autonomous immunity protects against pathogens. Science 340:701-706
2. Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 5:219-226
3. Eizirik DL, Sammeth M, Bouckenooghe T et al (2012) The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 8:e1002552
4. Bergholdt R, Brorsson C, Palleja A et al (2012) Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 61:954-962
5. Santin I, Eizirik DL (2013) Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and β-cell apoptosis. Diabetes Obes Metab 3:71-81
6. Eizirik DL, Miani M, Cardozo AK (2013) Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56:234-241
7. Chen MC, Proost P, Gysemans C, Mathieu C, Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells. Diabetologia 44:325-332
8. Cardozo AK, Kruhøffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50:909-920
9. Roep BO, Peakman M (2011) Diabetogenic T lymphocytes in human type 1 diabetes. Curr Opin Immunol 23:746-753
10. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL (2003) IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46:255-266
11. Roep BO, Kleijwegt FS, van Halteren AG et al (2010) Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 159:338-343
12. Bluestone JA, Herold K, Eisenbarth G (2012) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293-1300
13. Crome SQ, Wang AY, Levings MK (2010) Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 159:109-119
14. Patel DD, Lee DM, Kolbinger F, Antoni C (2013) Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis 72(Suppl 2):ii116-ii123
15. Emamaullee JA, Davis J, Merani S et al (2009) Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58:1302-1311
16. Honkanen J, Nieminen JK, Gao R et al (2010) IL-17 immunity in human type 1 diabetes. J Immunol 185:1959-1967
17. Arif S, Moore F, Marks K et al (2011) Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death. Diabetes 60:2112-2119
18. Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C (2009) Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 39:216-224
19. Ferraro A, Socci C, Stabilini A et al (2011) Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 60:2903-2913
20. Miljkovic D, Cvetkovic I, Momcilovic M, Maksimovic-Ivanic D, Stosic-Grujicic S, Trajkovic V (2005) Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse β-cells. Cell Mol Life Sci 62:2658-2668
21. Gysemans CA, Ladrière L, Callewaert H et al (2005) Disruption of the γ-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of β-cells. Diabetes 54:2396-2403
22. Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437-1442
23. Moore F, Colli ML, Cnop M et al (2009) PTPN2, a candidate gene for type 1 diabetes, modulates interferon-γ-induced pancreatic β-cell apoptosis. Diabetes 58:1283-1291
24. Gysemans C, Callewaert H, Moore F et al (2009) Interferon regulatory factor-1 is a key transcription factor in murine β-cells under immune attack. Diabetologia 52:2374-2384
25. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167-178
26. Nogueira TC, Paula FM, Villate O et al (2013) GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic β-cell apoptosis via regulation of a splice variant of the BH3-Only protein Bim. PLoS Genet 9:e1003532
27. Ravassard P, Hazhouz Y, Pechberty S et al (2011) A genetically engineered human pancreatic β-cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 121:3589-3597
28. Eizirik DL, Mandrup-Poulsen T (2001) A choice of death -the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44:2115-2133
29. Kutlu B, Cardozo AK, Darville MI et al (2003) Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52:2701-2719
30. Ortis F, Cardozo AK, Crispim D, Störling J, Mandrup-Poulsen T, Eizirik DL (2006) Cytokine-induced proapoptotic gene expression in insulin-producing cells is related to rapid, sustained, and nonoscillatory nuclear factor-kappaB activation. Mol Endocrinol 20:1867-1879
31. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A (1994) Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci U S A 91:9253-9256
32. Eizirik DL, Sandler S, Welsh N et al (1994) Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 93:1968-1974
33. Moore F, Cunha DA, Mulder H, Eizirik DL (2012) Use of RNA interference to investigate cytokine signal transduction in pancreatic β-cells. Methods Mol Biol 820:179-194
34. Moore F, Santin I, Nogueira TC et al (2012) The transcription factor C/EBP delta has anti-apoptotic and anti-inflammatory roles in pancreatic β-cells. PLoS One 7:e31062
35. Hoorens A, van de Casteele M, Klöppel G, Pipeleers D (1999) Glucose promotes survival of rat pancreatic β-cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568-1574
36. Rasschaert J, Ladrière L, Urbain M et al (2005) Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA + interferon-γ-induced apoptosis in primary pancreatic β-cells. J Biol Chem 280:33984-33991
37. Overbergh L, Valckx D, Waer M, Mathieu C (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11:305-312
38. Marhfour I, Lopez XM, Lefkaditis D et al (2012) Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia 55:2417-2420
39. Shalom-Barak T, Quach J, Lotz M (1998) Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB. Biol Chem 273:27467-27473
40. Schwandner R, Yamaguchi K, Cao Z (2000) Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 191:1233-1240
41. Moore F, Naamane N, Colli ML et al (2011) STAT1 is a master regulator of pancreatic β-cell apoptosis and islet inflammation. J Biol Chem 286:929-941
42. Ortis F, Naamane N, Flamez D et al (2010) Cytokines interleukin-1β and tumor necrosis factor-α regulate different transcriptional and alternative splicing networks in primary β-cells. Diabetes 59:358-374
43. Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610-621
44. Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P (2007) Role of chemokines in endocrine autoimmune diseases. Endocr Rev 28:492-520
45. Valle A, Giamporcaro GM, Scavini M et al (2013) Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes 62:2072-2077
46. Martin AP, Rankin S, Pitchford S, Charo IF, Furtado GC, Lira SA (2008) Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes. Diabetes 57:3025-3033
47. Kriegel MA, Rathinam C, Flavell RA (2012) Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c + CD11b + dendritic cells. Proc Natl Acad Sci U S A 109:3457-3462
48. Sarkar SA, Lee CE, Victorino F et al (2012) Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 61:436-446
49. Kuriya G, Uchida T, Akazawa S et al (2013) Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse. Diabetologia 56:1773-1780
50. Zhu S, Pan W, Song X et al (2012) The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med 18:1077-1086